ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
40.90
0.15
( 0.37% )
Updated: 03:08:17

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
40.90
Bid
40.85
Ask
40.95
Volume
571
40.70 Day's Range 40.90
39.55 52 Week Range 67.40
Market Cap
Previous Close
40.75
Open
40.85
Last Trade
6
@
40.9
Last Trade Time
03:10:10
Financial Volume
-
VWAP
-
Average Volume (3m)
9,092
Shares Outstanding
15,007,208
Dividend Yield
3.06%
PE Ratio
13.00
Earnings Per Share (EPS)
3.14
Revenue
222.57M
Net Profit
47.05M

About Equasens

Sector
Computer Programming Service
Industry
Computer Programming Service
Headquarters
Nancy, Meurthe-et-moselle, Fra
Founded
-
Equasens is listed in the Computer Programming Service sector of the Euronext with ticker EQS. The last closing price for Equasens was 40.75 €. Over the last year, Equasens shares have traded in a share price range of 39.55 € to 67.40 €.

Equasens currently has 15,007,208 shares outstanding. The market capitalization of Equasens is 611.54 € million. Equasens has a price to earnings ratio (PE ratio) of 13.00.

EQS Latest News

EQUASENS : bilan semestriel S2 2024 du contrat de liquidité contracté avec Gilbert Dupont

EQUASENS : bilan semestriel S2 2024 du contrat de liquidité contracté avec Gilbert Dupont Villers-lès-Nancy, le 08 janvier 2025 - 18h00 (CET) COMMUNIQUE DE PRESSE BILAN SEMESTRIEL S2-2024 DU...

EQUASENS : acquisition stratégique de Calimed, expert en logiciel SaaS pour les médecins libéraux et les chirurgiens

EQUASENS : acquisition stratégique de Calimed, expert en logiciel SaaS pour les médecins libéraux et les chirurgiens Villers-lès-Nancy, le 27 décembre 2024 – 18h00 (CET)COMMUNIQUE DE PRESSE...

Equasens: strategic acquisition of Calimed, a SaaS software expert for private practitioners and surgeons

Equasens: strategic acquisition of Calimed, a SaaS software expert for private practitioners and surgeons Villers-lès-Nancy, 27 December 2024 - 6:00 p.m. (CET)PRESS RELEASE Equasens strengthens...

EQUASENS : Digipharmacie obtient l’immatriculation officielle en tant que Plateforme de Dématérialisation Partenaire (PDP)

EQUASENS : Digipharmacie obtient l’immatriculation officielle en tant que Plateforme de Dématérialisation Partenaire (PDP) Villers-lès-Nancy, le 21 novembre 2024 – 18h00 (CET)COMMUNIQUE DE PRESSE...

EQUASENS : Intelligence artificielle : Equasens et Posos transforment la dispensation pharmaceutique

EQUASENS : Intelligence artificielle : Equasens et Posos transforment la dispensation pharmaceutique Villers-lès-Nancy, le 20 novembre 2024 – 18h00 (CET)COMMUNIQUE DE PRESSE Le Groupe Equasens et...

EQUASENS : Chiffre d’affaires au 30 septembre 2024 à 158,2 M€ - Retour de la croissance sur le T3 (+0,3%)

EQUASENS : Chiffre d’affaires au 30 septembre 2024 à 158,2 M€ - Retour de la croissance sur le T3 (+0,3%) Villers-lès-Nancy, le 7 novembre 2024 - 18h00 (CET) COMMUNIQUE DE PRESSE Chiffre...

Equasens: 2024 nine-month revenue: €158.2 million - Return to growth in Q3 (+0.3%)

Equasens: 2024 nine-month revenue: €158.2 million - Return to growth in Q3 (+0.3%) Villers-lès-Nancy, 7 November 2024 - 6:00 p.m. (CET) PRESS RELEASE 2024 nine-month revenue:...

EQUASENS : Modalités de mise à disposition du rapport financier semestriel 2024

EQUASENS : Modalités de mise à disposition du rapport financier semestriel 2024 Villers-lès-Nancy, le 30 septembre 2024 - 20h00 (CET) COMMUNIQUE DE PRESSE EQUASENS annonce la publication de son...

Equasens: 2024 half-year results

Equasens: 2024 half-year results Villers-lès-Nancy, 27 September 2024 - 6:00 p.m. (CET) PRESS RELEASE 2024 half-year results Group results impacted by weaker economic conditions and continuing...

EQUASENS : Résultats semestriels 2024

EQUASENS : Résultats semestriels 2024 Villers-lès-Nancy, le 27 septembre 2024 - 18h00 (CET) COMMUNIQUE DE PRESSE Résultats semestriels 2024 Une conjoncture économique dégradée et un maintien des...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-4.1-9.111111111114545.240.51109841.57087906DE
4-1.1-2.61904761905424640.5825843.00602432DE
12-10.9-21.042471042551.853.339.55909243.87657286DE
26-8.6-17.373737373749.556.739.55799246.39998475DE
52-16.2-28.371278458857.167.439.55961751.54407731DE
156-43.1-51.30952380958486.639.55632359.77591738DE
260-43.1-51.30952380958486.639.55632359.77591738DE

EQS - Frequently Asked Questions (FAQ)

What is the current Equasens share price?
The current share price of Equasens is 40.90 €
How many Equasens shares are in issue?
Equasens has 15,007,208 shares in issue
What is the market cap of Equasens?
The market capitalisation of Equasens is EUR 611.54M
What is the 1 year trading range for Equasens share price?
Equasens has traded in the range of 39.55 € to 67.40 € during the past year
What is the PE ratio of Equasens?
The price to earnings ratio of Equasens is 13
What is the cash to sales ratio of Equasens?
The cash to sales ratio of Equasens is 2.75
What is the reporting currency for Equasens?
Equasens reports financial results in EUR
What is the latest annual turnover for Equasens?
The latest annual turnover of Equasens is EUR 222.57M
What is the latest annual profit for Equasens?
The latest annual profit of Equasens is EUR 47.05M
What is the registered address of Equasens?
The registered address for Equasens is 5 ALLEE DE SAINT-CLOUDN BP117, NANCY, MEURTHE-ET-MOSELLE, 54600
What is the Equasens website address?
The website address for Equasens is www.equasens.com
Which industry sector does Equasens operate in?
Equasens operates in the COMPUTER PROGRAMMING SERVICE sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ALCYBCybergun
0.0002 €
(100.00%)
5.1M
HYPDSHipay Group DS
0.001 €
(25.00%)
1.44k
ALTHOMetavisio (Thomson Computing)
0.2415 €
(18.97%)
302.63k
CNVCnova NV
0.144 €
(18.52%)
100
PROACProactis SA
0.066 €
(16.81%)
1,000
TDBSTonner Drones
0.0008 €
(-11.11%)
220k
ALTHETheraclion
0.252 €
(-10.00%)
4k
ALSGDSpineguard
0.222 €
(-9.57%)
130.27k
ALUPGUpergy
1.61 €
(-9.55%)
10k
ALMCPMcphy Energy
1.156 €
(-8.25%)
30.93k
ATOAtos SE
0.002 €
(0.00%)
113.53M
ALCYBCybergun
0.0002 €
(100.00%)
5.1M
BCPBanco Comercial Portugues SA
0.4772 €
(-0.62%)
1.9M
ALADOAdomos
0.0002 €
(0.00%)
1.08M
ALAGOEPango SA
0.1998 €
(9.30%)
744.37k

Discussion

View Full Feed
Hi_Lo Hi_Lo 3 minutes ago
Lol!! I want profits!! What you want helps me in no way!!
Exactly. Because the truth with documentation that BCAP is a scam and Jake P. Noch is a serial scammer prevents pumping liars like you from making profits. And that's part of my goal - and to help people know the facts about this scam
BCAP
DiamondHealer95 DiamondHealer95 6 minutes ago
What do you expect and how can you back your thoughts? Thanks
KBLB
DiamondHealer95 DiamondHealer95 12 minutes ago
I mean Kim said once they hit 1.5 metric tons they're open for business and they're about halfway there so..... You're a genius! Congrats on the business. I also run one with 100% positive feedback over 22 years so I get the perspective🤪

Also, in my Arby's voice "I have the
KBLB
DiamondHealer95 DiamondHealer95 16 minutes ago
We've invested similarly
KBLB
sunspotter sunspotter 27 minutes ago
Glenn Miller’s still missing, and Emil Malak and Rich Inza are still crooks.
VPLM
Flobewan Flobewan 38 minutes ago
Marc loved your ides
tinojax tinojax 39 minutes ago
I usually enjoy a beer with my pizza...........I would like to know what's in the Kool Aid........
PLUG
mrfence mrfence 41 minutes ago
Here we are on the cusp of the Monsta $FMCC~ $FNMA~ Gains we've all been waiting for doin da Heebie Jeebie Dance, 😃😄😁😆😅😂!
[yt]MUB3ZR4F8vw?si=Z3oB5zc_RHMtCGEY[/yt]
FMCC FNMA
IVRT IVRT 57 minutes ago
In my opinion, there will likely be significant pressure on the share price leading up to the conference call. A sell-off could occur the day before, with the stock potentially bottoming out by the end of the investor call. I could be wrong, but I've seen similar patterns many times over the past 25
BMXI
DewDiligence DewDiligence 57 minutes ago
GSK acquires—(private)—IDRx for $1B up-front + $150M contingency:

https://www.businesswire.com/news/home/20250112698434/en • Acquisition includes IDRX-42, a highly selective KIT tyrosine kinase inhibitor (TKI) designed to treat gastrointestinal stromal tumours (GIST)

ENTA
DewDiligence DewDiligence 58 minutes ago
GSK acquires—(private)—IDRx for $1B up-front + $150M contingency:

https://www.businesswire.com/news/home/20250112698434/en • Acquisition includes IDRX-42, a highly selective KIT tyrosine kinase inhibitor (TKI) designed to treat gastrointestinal stromal tumours (GIST)

Guido2 Guido2 59 minutes ago
This is DUE DILIGENCE! Thank you Free Fannie.

https://x.com/freefannie/status/1878655047715991552?s=46&t=2Y42DPZFgRdwTBHj5W8jMQ
FNMA
StockItOut StockItOut 1 hour ago
That Xeriant PR excellently written with bullshit:

""After successfully completing 75% of the demanding NFPA 286 test," meaning = "after failing the NFPA 286 test by missing 25% of the approval target testing requirement,"

"the Company used the data to make several key
XERI
gitreal gitreal 1 hour ago
You were actually partially right....BMXI has filed some SEC documents, some necessary (Form 1-A), some unnecessary (Form 4). And they do summarize a lot of the stuff that I think are fabrications....their production, mining operations, etc. Time will tell, but I think a lot of it (and probably
BMXI
RichieBoy RichieBoy 1 hour ago
Jim wrote a blurb about seeking more US business.

Help you out any? 🤨
AFFU
DesktopDR DesktopDR 1 hour ago
Any news or updates?
VPLM
Tahoe2468 Tahoe2468 1 hour ago
.0915 by Thursday....... 
KRTL
skitahoe skitahoe 1 hour ago
Remember GBM was redefined during the trial, thus some who were treated then had other forms of brain cancer. I believe the least we'll see in our label is brain cancer. Certainly GBM may be the deadliest of them, but treatment should work in all of them.

According to Google, GBM ha
NWBO
fuagf fuagf 1 hour ago
You are right about the crafty, evil, smart. Authoritarian methods have been in full view
in capturing America. While we work to do the right things they plot to capture the lot.
facts_matter14 facts_matter14 1 hour ago
If there weren’t suckers born every minute, there wouldn’t be POSRMX bag holders down as much as 99%, and there sure as hell wouldn’t be anybody believing there is a pipeline of products.






.
SRMX
StockItOut StockItOut 1 hour ago
Your "closer" keeps getting extended. Then again extended. Then again extended. -- Consider that end. Now expired, horizon end now reached, and the view clarifies and we see it to be your desperation from years ago ongoing still, to pump this at any expense, where you attempt to instill FOMO to hold
XERI
fuagf fuagf 2 hours ago
He would smother any question with words.

Your Recent History

Delayed Upgrade Clock